By GREGORY ZELLER // Farmingdale pharmaceutical firm DepYmed is no stranger to capital investments – but a new infusion might be enough to push the rare-disease innovator over the commercialization…
By GREGORY ZELLER // These boots are made for talking – and now, several enterprising innovators have a firmer grasp on what to say, and how to say it, when…
By GREGORY ZELLER // A cutting-edge Long Island biotech with a unique cancer-fighting platform has closed a critical $2 million funding round. DepYmed Inc., spun out of Cold Spring Harbor…
By Gregory Zeller // A Cold Spring Harbor biotech startup is the 10th and final recipient in the first co-funding round backed by Accelerate Long Island and the Long Island…
A joint venture between biotech stalwart Ohr Pharmaceutical and Cold Spring Harbor Laboratory is taking the fight to breast cancer – though a revolutionary treatment may still be a half-decade…